Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22833| Title: | SJS/TEN 2019: From science to translation. | Austin Authors: | Chang, Wan-Chun;Abe, Riichiro;Anderson, Paul;Anderson, Wanpen;Ardern-Jones, Michael R;Beachkofsky, Thomas M;Bellón, Teresa;Biala, Agnieszka K;Bouchard, Charles;Cavalleri, Gianpiero L;Chapman, Nicole;Chodosh, James;Choi, Hyon K;Cibotti, Ricardo R;Divito, Sherrie J;Dewar, Karen;Dehaeck, Ulrike;Etminan, Mahyar;Forbes, Diane;Fuchs, Esther;Goldman, Jennifer L;Holmes, James H;Hope, Elyse A;Hung, Shuen-Iu;Hsieh, Chia-Ling;Iovieno, Alfonso;Jagdeo, Julienne;Kim, Mee Kum;Koelle, David M;Lacouture, Mario E;Le Pallec, Sophie;Lehloenya, Rannakoe J;Lim, Robyn;Lowe, Angie;McCawley, Jean;McCawley, Julie;Micheletti, Robert G;Mockenhaupt, Maja;Niemeyer, Katie;Norcross, Michael A;Oboh, Douglas;Olteanu, Cristina;Pasieka, Helena B;Peter, Jonathan;Pirmohamed, Munir;Rieder, Michael;Saeed, Hajirah N;Shear, Neil H;Shieh, Christine;Straus, Sabine;Sukasem, Chonlaphat;Sung, Cynthia;Trubiano, Jason ;Tsou, Sheng-Ying;Ueta, Mayumi;Volpi, Simona;Wan, Chen;Wang, Hongsheng;Wang, Zhao-Qing;Weintraub, Jessica;Whale, Cindy;Wheatley, Lisa M;Whyte-Croasdaile, Sonia;Williams, Kristina B;Wright, Galen;Yeung, Sonia N;Zhou, Li;Chung, Wen-Hung;Phillips, Elizabeth J;Carleton, Bruce C | Affiliation: | Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan Association des malades des syndromes de Lyell et de Stevens-Johnson (Amalyste), Paris, France Institute of Dermatology, Chinese Academy of Medical Sciences, National Center for STD and Leprosy Control, China CDC, Nanjing, China Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base, TX, USA SJS Awareness Oregon, Klamath Falls, OR, USA Stevens-Johnson Syndrome Foundation, Westminster, CO, USA SJ Syndrome of Texas, Austin, TX, USA Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA Division of Pharmacovigilance I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA National Human Genome Research Institute, NIH, Bethesda, MD, USA Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, TN, USA Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA Department of Dermatology, MedStar Washington Hospital Center, Washington, DC, USA Laboratory of Immunology, Division of Biotechnology Review and Research III (DBRR III), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Medicine, University of Washington, Seattle, WA, USA Wake Forest University School of Medicine, WFBMC Burn Center, Winston-Salem, NC, USA Children's Mercy Hospital Kansas City, Kansas City, MO, USA Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, USA Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA Loyola University Medical Center, Chicago, IL, USA Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea School of Pharmacy and Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK Drug Hypersensitivity Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada Genome Canada, Ottawa, ON, Canada Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada Canadian Institutes of Health Research, Ottawa, ON, Canada Genome British Columbia, Vancouver, BC, Canada Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan Eden Social Welfare Foundation, Taipei, Taiwan Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada Genome British Columbia, Vancouver, BC, Canada Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa Health Products and Food Branch, Health Canada, Ottawa, ON, Canada SJS/TEN International Awareness (STIA), Lucky Lake, SK, Canada Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK Department of Paediatrics, Children's Hospital/London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada Dutch Medicines Evaluation Board, Pharmacovigilance Risk Assessment Committee, European Medicines Agency, Utrecht, the Netherlands Health Products Regulation Group, Health Sciences Authority Singapore, Duke-NUS Medical School, Singapore Eden Social Welfare Foundation, Taipei, Taiwan Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan Genome British Columbia, Vancouver, BC, Canada Eden Social Welfare Foundation, Taipei, Taiwan SJS Canada, Brantford, ON, Canada Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Keelung, Taoyuan, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan. Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. |
Issue Date: | Apr-2020 | Date: | 2020-03-07 | Publication information: | Journal of Dermatological Science 2020; 98(1): 2-12 | Abstract: | Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26-27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22833 | DOI: | 10.1016/j.jdermsci.2020.02.003 | ORCID: | 0000-0002-5111-6367 | Journal: | Journal of dermatological science | PubMed URL: | 32192826 | Type: | Journal Article | Subjects: | Human leukocyte antigen (HLA) Pharmacogenomics Pharmacovigilance Severe cutaneous adverse reaction (SCAR) Stevens-Johnson syndrome (SJS) Toxic epidermal necrolysis (TEN) |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.